SOX2 and glioma: Ikushima et al. showed that inhibition of TGF-beta signaling drastically deprived tumorigenicity of glioma-initiating cells (GICs) by promoting their differentiation, and that these effects were attenuated in GICs transduced with SOX2 or SOX4 [20].